{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:07:11Z","timestamp":1769573231031,"version":"3.49.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lungcan.2025.108807","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:17:07Z","timestamp":1762186627000},"page":"108807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-7908","authenticated-orcid":false,"given":"Paolo","family":"Borghetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"D\u2019Angelillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4555-1725","authenticated-orcid":false,"given":"Giorgio","family":"Facheris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-2923","authenticated-orcid":false,"given":"Andrea","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1068-5958","authenticated-orcid":false,"given":"Alessio","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-7689","authenticated-orcid":false,"given":"Paolo","family":"Ceruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-7869","authenticated-orcid":false,"given":"Andrea Riccardo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Badellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Balestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ciammella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cuccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2 Giaj","family":"Levra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Larici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Mondoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Palmucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Piperno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vieri","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Sepulcri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Sverzellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trov\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Vagge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Varone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"SUPPL 5","key":"10.1016\/j.lungcan.2025.108807_b0005","article-title":"Interstitial lung disease guideline: the british thoracic society in collaboration with the thoracic society of Australia and New Zealand and the irish thoracic society","volume":"63","author":"Wells","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"19","key":"10.1016\/j.lungcan.2025.108807_b0015","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108807_b0020","series-title":"A Primer on Interstitial Lung Disease and Thoracic Radiation","author":"Goodman","year":"2020"},{"key":"10.1016\/j.lungcan.2025.108807_b0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2020.11.020","article-title":"Idiopathic pulmonary fibrosis: current knowledge, future perspectives and its importance in radiation oncology","volume":"155","author":"T\u00fcrkkan","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"13","key":"10.1016\/j.lungcan.2025.108807_b0030","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.lungcan.2025.108807_b0035","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108807_b0040","article-title":"Alternatives to surgery for early-stage non\u2013small cell lung cancer: stereotactic radiotherapy","author":"Beaty","year":"2020","journal-title":"W.B. Saunders"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108807_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2025.108807_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104247","article-title":"Management of patients with extensive small-cell lung cancer in the immunotherapy era: an italian consensus through a Delphi approach","author":"Ceresoli","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0030-5073(73)90052-4","article-title":"A comparative study of differences in subjective likelihood estimates made by individuals, interacting groups, Delphi groups, and nominal groups","volume":"9","author":"Gustafson","year":"1973","journal-title":"Organ. Behav. Hum. Perform."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108807_b0065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/09537325.2014.941348","article-title":"Exploring the application of the delphi method as a forecasting tool in information systems and technologies research","volume":"26","author":"Gallego","year":"2014","journal-title":"Technol Anal Strateg Manag"},{"key":"10.1016\/j.lungcan.2025.108807_b0070","unstructured":"K. Fitch et al., \u201cThe RAND\/UCLA Appropriateness Method User\u2019s Manual,\u201d 2001, Accessed: Apr. 24, 2024. [Online]. Available: https:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0075","article-title":"High-resolution computed tomography technique and radiation dose in interstitial lung disease: pearls and pitfalls","volume":"8","author":"Borghesi","year":"2021","journal-title":"J. Radiol. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0080","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2021200279","article-title":"Practical imaging interpretation in patients suspected of having idiopathic pulmonary fibrosis: official recommendations from the radiology working group of the pulmonary fibrosis foundation","volume":"3","author":"Hobbs","year":"2021","journal-title":"Radiol. Cardiothorac. Imaging"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2025.108807_b0090","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6602061","article-title":"The epidemiology of interstitial lung disease and its association with lung cancer","volume":"91","author":"Raghu","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0095","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.29119","article-title":"Imaging of pulmonary fibrosis: an update, from the AJR special series on imaging of fibrosis","volume":"222","author":"Lee","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108807_b0100","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clon.2022.01.043","article-title":"Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? A systematic review","volume":"34","author":"Saha","year":"2022","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108807_b0105","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.12659\/MSM.902353","article-title":"The cellular and molecular mechanism of radiation-induced lung injury","volume":"23","author":"Huang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lungcan.2025.108807_b0110","series-title":"Idiopathic Pulmonary Fibrosis: Current Knowledge, Future Perspectives and its Importance in Radiation Oncology","author":"T\u00fcrkkan","year":"2021"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108807_b0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4143\/crt.2014.180","article-title":"Interstitial lung change in pre-radiation therapy computed tomography is a risk factor for severe radiation pneumonitis","volume":"47","author":"Lee","year":"2015","journal-title":"Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108807_b0120","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.7150\/jca.24936","article-title":"Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage III non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy","volume":"9","author":"Kobayashi","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer","volume":"10","author":"Ueki","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1183\/09031936.02.00492002","article-title":"ATS\/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"19","author":"Demedts","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108807_b0135","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0140","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.21037\/jtd.2018.05.75","article-title":"Lung cancer and interstitial lung disease: a literature review","volume":"10","author":"Naccache","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oncolo\/oyac226","article-title":"Management of lung cancer in the patient with interstitial lung disease","volume":"28","author":"Frank","year":"2023","journal-title":"Oncologist"},{"issue":"Suppl 3","key":"10.1016\/j.lungcan.2025.108807_b0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.rx.2022.10.008","article-title":"Smoking-related interstitial lung disease","volume":"64","author":"Serrano Gotarredona","year":"2022","journal-title":"Radiologia"},{"issue":"10","key":"10.1016\/j.lungcan.2025.108807_b0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lungcan.2025.108807_b0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2017.04.012","article-title":"The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease","volume":"127","author":"Morisset","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.lungcan.2025.108807_b0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rmed.2019.02.015","article-title":"The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease","volume":"150","author":"Brusca","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.lungcan.2025.108807_b0170","article-title":"ILD-GAP combined with the charlson comorbidity index score (ILD-GAPC) as a prognostic prediction model in patients with interstitial lung disease","volume":"2023","author":"Fujii","year":"2023","journal-title":"Can. Respir. J."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108807_b0175","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00957-2022","article-title":"Idiopathic pulmonary fibrosis: state of the art for 2023","volume":"61","author":"Podolanczuk","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0398-4","article-title":"A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)","volume":"17","author":"Iwata","year":"2016","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037186","article-title":"Selection of the appropriate treatment for the combination of interstitial lung disease and lung cancer: a retrospective observational study","volume":"103","author":"Karapinar","year":"2024","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108807_b0190","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2017.03.010","article-title":"Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review","volume":"98","author":"Chen","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108807_b0195","first-page":"4909","article-title":"Impact of interstitial changes on radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"35","author":"Yoshitake","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2025.108807_b0200","doi-asserted-by":"crossref","unstructured":"S. Bisello et al., Dose\u2013Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An \u2018All-in-One\u2019 Multicenter\u2013Multidisciplinary Practical Summary, 2022, MDPI. doi: 10.3390\/curroncol29100552.","DOI":"10.3390\/curroncol29100552"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaoncol.2023.7269","article-title":"Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial","volume":"10","author":"Palma","year":"2024","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0210","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01798-2","article-title":"Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy","volume":"16","author":"Li","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyz016","article-title":"Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities","volume":"49","author":"Higo","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108807_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109454","article-title":"Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer","volume":"180","author":"Kashihara","year":"2023","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108807_b0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9779","key":"10.1016\/j.lungcan.2025.108807_b0230","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.lungcan.2025.108807_b0235","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108807_b0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.lungcan.2025.108807_b0245","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-0977-2","article-title":"Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry","volume":"20","author":"Zurkova","year":"2019","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0255","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","article-title":"Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"160","author":"Petnak","year":"2021","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.lungcan.2025.108807_b0260","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0265","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.07-0323","article-title":"Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis","volume":"132","author":"Park","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41584-021-00721-z","article-title":"Acute exacerbation of interstitial lung disease associated with rheumatic disease","volume":"18","author":"Luppi","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0275","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.1186\/s12890-019-0960-1","article-title":"Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study","volume":"19","author":"Cao","year":"2019","journal-title":"BMC Pulm. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/resp.13682","article-title":"Acute exacerbations of fibrotic interstitial lung diseases","volume":"25","author":"Suzuki","year":"2020","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0285","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1186\/s12931-021-01748-2","article-title":"Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes","volume":"22","author":"Kang","year":"2021","journal-title":"Respir. Res."},{"issue":"3\u20134","key":"10.1016\/j.lungcan.2025.108807_b0290","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2152\/jmi.63.294","article-title":"Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease","volume":"63","author":"Toyoda","year":"2016","journal-title":"J. Med. Invest."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108807_b0295","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2025.108807_b0300","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.2147\/COPD.S210759","article-title":"Impact of underlying pulmonary diseases on treatment outcomes in early-stage non-small cell lung cancer treated with definitive radiotherapy","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0305","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.21037\/tlcr-20-1050","article-title":"Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2017.06.021","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT)","volume":"19","author":"Glick","year":"2018","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108807_b0315","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108807_b0325","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1111\/cas.14217","article-title":"Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease","volume":"110","author":"Kenmotsu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2025.108807_b0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2019.09.020","article-title":"A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)","volume":"138","author":"Asahina","year":"2019","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0335","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2010.04.014","article-title":"The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias","volume":"71","author":"Minegishi","year":"2011","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108807_b0340","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10147-019-01516-9","article-title":"Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study","volume":"24","author":"Fukuizumi","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108807_b0345","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/JTO.0b013e318216ee6b","article-title":"The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer","volume":"6","author":"Kenmotsu","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108807_b0350","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00432-016-2199-z","article-title":"Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival","volume":"142","author":"Kanaji","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0355","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.21873\/invivo.11704","article-title":"Pemetrexed plus platinum for patients with advanced non-small cell lung cancer and interstitial lung disease","volume":"33","author":"Fujita","year":"2019","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0360","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-508","article-title":"Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease","volume":"14","author":"Kato","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0365","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1183\/13993003.00380-2022","article-title":"Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial","volume":"60","author":"Otsubo","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108807_b0370","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.1001\/jamanetworkopen.2020.22906","article-title":"Association of preexisting interstitial lung abnormalities with immune checkpoint inhibitor-induced interstitial lung disease among patients with nonlung cancers","volume":"3","author":"Shimoji","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.lungcan.2025.108807_b0375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2021.03.014","article-title":"Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease","volume":"155","author":"Tasaka","year":"2021","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0380","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.chest.2021.12.656","article-title":"Clinical outcomes of immune checkpoint inhibitor therapy in patients with advanced non-small cell lung cancer and preexisting interstitial lung diseases: a systematic review and meta-analysis","volume":"161","author":"Zhang","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2025.108807_b0385","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.lungcan.2019.06.001","article-title":"Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: a multicenter, open-label single-arm phase II trial","volume":"134","author":"Fujimoto","year":"2019","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2025.108807_b0390","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/oncolo\/oyac118","article-title":"Atezolizumab for pretreated non-small cell lung cancer with idiopathic interstitial pneumonia: final analysis of phase II AMBITIOUS study","volume":"27","author":"Ikeda","year":"2022","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108807_b0395","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/1759-7714.13725","article-title":"Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression \u226550% on first-line pembrolizumab","volume":"12","author":"Yamaguchi","year":"2021","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0405","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.20130790","article-title":"RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance","volume":"211","author":"Xiao","year":"2014","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108807_b0410","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/his.13103","article-title":"The pathological features of idiopathic interstitial pneumonia-associated pulmonary adenocarcinomas","volume":"70","author":"Kojima","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108807_b0415","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0605-y","article-title":"Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses","volume":"18","author":"Guyard","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.lungcan.2025.108807_b0420","first-page":"405","article-title":"High prevalence of drug-induced Pneumonia in Japan","volume":"50","author":"Azuma","year":"2007","journal-title":"Japan Med. Assoc. J."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108807_b0425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa2112431","article-title":"Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer","volume":"386","author":"Li","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108807_b0430","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.prro.2016.01.009","article-title":"Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease","volume":"6","author":"Bahig","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108807_b0435","doi-asserted-by":"crossref","first-page":"Dec","DOI":"10.1183\/13993003.00276-2021","article-title":"A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease","volume":"58","author":"Ryerson","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2025.108807_b0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lungcan.2018.07.032","article-title":"Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study","volume":"124","author":"Stone","year":"2018","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108807_b0445","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.athoracsur.2021.03.017","article-title":"Impact of a thoracic multidisciplinary conference on lung cancer outcomes","volume":"113","author":"Gaudioso","year":"2022","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2025.108807_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107822","article-title":"Optimal management of radiation pneumonitis: findings of an international Delphi consensus study","volume":"192","author":"Voruganti Maddali","year":"2024","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T21:52:48Z","timestamp":1764798768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":90,"alternative-id":["S0169500225006993"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108807","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108807"}}